Atsuko Matsuoka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Atsuko Matsuoka has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
Toshie Tsuchiya
National Institute of Health Sciences
5 shared publicationsAgneta Önfelt
Department of Environmental Chemistry, Stockholm University, Stockholm, Sweden
3 shared publicationsHiroko Sakamoto
Division of Genetics and Mutagenesis, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
3 shared publicationsKiyoshi Fukuhara
3 shared publicationsM Hayashi
3 shared publicationsMakoto Hayashi
Division of Genetics and Mutagenesis, National Institute of Health Sciences, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan
3 shared publications
Latest Publications
- 20 March 2013
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 16 (3) , 284-293
Study on the potential of RGD- and PHSRN-modified alginates as artificial extracellular matrices for engineering bone
Alginate is a polysaccharide that can be crosslinked by divalent cations, such as calcium ions, to form a gel. Chemical modification is typically used to improve its cell adhesive properties for tissue engineering applications. In this study, alginates were modified with peptides containing RGD (arginine–glycine–aspartic acid) or PHSRN (proline–histidine–serine–arginine–asparagine) sequences from fibronectin to study possible additive and synergistic effects on adherent cells. Alginates modified with each peptide were mixed at different ratios to form gels containing various concentrations and spacing between the RGD and PHSRN sequences. When normal human osteoblasts (NHOsts) were cultured on or in the gels, the ratio of RGD to PHSRN was found to influence cell behaviors, especially differentiation. NHOsts cultured on gels composed of RGD- and PHSRN-modified alginates showed enhanced differentiation when the gels contained >33 % RGD-alginate, suggesting the relative distribution of the peptides and the presentation to cells are important parameters in this regulation. NHOsts cultured in gels containing both RGD- and PHSRN-alginates also demonstrated a similar enhancement tendency of calcium deposition that was dependent on the peptide ratio in the gel. However, calcium deposition was greater when cells were cultured in the gels, as compared to on the gels. These results suggest that modifying this biomaterial to more closely mimic the chemistry of natural cell adhesive proteins, (e.g., fibronectin) may be useful in developing scaffolds for bone tissue engineering and provide three-dimensional cell culture systems which more closely mimic the environment of the human body.
- 20 March 2013
- Published by Springer Nature in Journal of Artificial Organs
- Vol. 16 (3) , 284-293
Study on the potential of RGD- and PHSRN-modified alginates as artificial extracellular matrices for engineering bone
Alginate is a polysaccharide that can be crosslinked by divalent cations, such as calcium ions, to form a gel. Chemical modification is typically used to improve its cell adhesive properties for tissue engineering applications. In this study, alginates were modified with peptides containing RGD (arginine–glycine–aspartic acid) or PHSRN (proline–histidine–serine–arginine–asparagine) sequences from fibronectin to study possible additive and synergistic effects on adherent cells. Alginates modified with each peptide were mixed at different ratios to form gels containing various concentrations and spacing between the RGD and PHSRN sequences. When normal human osteoblasts (NHOsts) were cultured on or in the gels, the ratio of RGD to PHSRN was found to influence cell behaviors, especially differentiation. NHOsts cultured on gels composed of RGD- and PHSRN-modified alginates showed enhanced differentiation when the gels contained >33 % RGD-alginate, suggesting the relative distribution of the peptides and the presentation to cells are important parameters in this regulation. NHOsts cultured in gels containing both RGD- and PHSRN-alginates also demonstrated a similar enhancement tendency of calcium deposition that was dependent on the peptide ratio in the gel. However, calcium deposition was greater when cells were cultured in the gels, as compared to on the gels. These results suggest that modifying this biomaterial to more closely mimic the chemistry of natural cell adhesive proteins, (e.g., fibronectin) may be useful in developing scaffolds for bone tissue engineering and provide three-dimensional cell culture systems which more closely mimic the environment of the human body.
- 1 January 2012
- No. 130,p. 13-20
[Industry regulation and its relationship to the rapid marketing of medical devices].
In the market of medical devices, non-Japanese products hold a large part even in Japan. To overcome this situation, the Japanese government has been announcing policies to encourage the medical devices industry, such as the 5-year strategy for medical innovation (June 6, 2012). The Division of Medical Devices has been contributing to rapid marketing of medical devices by working out the standards for approval review and accreditation of medical devices, guidances on evaluation of medical devices with emerging technology, and test methods for biological safety evaluation of medical devices, as a part of practice in the field of regulatory science. The recent outcomes are 822 standards of accreditation for Class II medical devices, 14 guidances on safety evaluation of medical devices with emerging technology, and the revised test methods for biological safety evaluation (MHLW Notification by Director, OMDE, Yakushokuki-hatsu 0301 No. 20 "Basic Principles of Biological Safety Evaluation Required for Application for Approval to Market Medical Devices").
- 1 January 2012
- No. 130,p. 13-20
[Industry regulation and its relationship to the rapid marketing of medical devices].
In the market of medical devices, non-Japanese products hold a large part even in Japan. To overcome this situation, the Japanese government has been announcing policies to encourage the medical devices industry, such as the 5-year strategy for medical innovation (June 6, 2012). The Division of Medical Devices has been contributing to rapid marketing of medical devices by working out the standards for approval review and accreditation of medical devices, guidances on evaluation of medical devices with emerging technology, and test methods for biological safety evaluation of medical devices, as a part of practice in the field of regulatory science. The recent outcomes are 822 standards of accreditation for Class II medical devices, 14 guidances on safety evaluation of medical devices with emerging technology, and the revised test methods for biological safety evaluation (MHLW Notification by Director, OMDE, Yakushokuki-hatsu 0301 No. 20 "Basic Principles of Biological Safety Evaluation Required for Application for Approval to Market Medical Devices").
- 1 January 2010
- No. 128,p. 65-70
Needle fibers of an azo-dye mixture induce polyploidy in a Chinese hamster cell line CHL.
In a routine Safety evaluation of chemicals included in household products, we found a mixture of azo dyes (CMBA, main component: N-[5-[(2-cyanoethyl)ethylamino]-4-methoxy-2-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl] acetamide) that precipitated in the culture medium in a characteristic fiber form (around 2 - 33 microm in length) similar to that of asbestos. We compared CMBA with an asbestos, chrysotile B, in a cytotoxicity, chromosome aberration (CA), and micronucleus (MN) test in a Chinese hamster lung cell line (CHL). In the cytotoxicity test, the 50% growth inhibition concentration was 11.0 microg/ml for CMBA and 0.398 microg/ml for chrysotile B asbestos. CMBA and chrysotile B both induced polyploidy in the CA test and equal-sized binucleated and polynuclear cells in the MN test. CMBA differs from chrysotile B chemically. The former is an organic chemical and the latter is a mineral. Although CMBA is soluble in methanol and can be safely disposed by burning, it should be handled carefully when manufactured in a factory.
- 1 January 2010
- No. 128,p. 65-70
Needle fibers of an azo-dye mixture induce polyploidy in a Chinese hamster cell line CHL.
In a routine Safety evaluation of chemicals included in household products, we found a mixture of azo dyes (CMBA, main component: N-[5-[(2-cyanoethyl)ethylamino]-4-methoxy-2-[(5-nitro-2,1-benzisothiazol-3-yl)azo]phenyl] acetamide) that precipitated in the culture medium in a characteristic fiber form (around 2 - 33 microm in length) similar to that of asbestos. We compared CMBA with an asbestos, chrysotile B, in a cytotoxicity, chromosome aberration (CA), and micronucleus (MN) test in a Chinese hamster lung cell line (CHL). In the cytotoxicity test, the 50% growth inhibition concentration was 11.0 microg/ml for CMBA and 0.398 microg/ml for chrysotile B asbestos. CMBA and chrysotile B both induced polyploidy in the CA test and equal-sized binucleated and polynuclear cells in the MN test. CMBA differs from chrysotile B chemically. The former is an organic chemical and the latter is a mineral. Although CMBA is soluble in methanol and can be safely disposed by burning, it should be handled carefully when manufactured in a factory.
- 1 January 2010
- No. 128,p. 50-7
[Cytogenetic study on safety evaluation of human mesenchymal stem cells cultured in vitro].
Human mesenchymal stem cells (hMSCs) are one of the promising sources for regenerative medicine. In general, hMSCs are supposed to grow indefinitely and differentiate to various kinds of cells. The indefinite growth is concerned due to its misleading to carcinogenesis in the practical use of hMSCs in regenerative medicine. In the present study, we investigated unexpected changes, especially in genetic aspect, in hMSCs during culture utilizing fluorescence in situ hybridization (FISH) with chromosome specific DNA probes for chromosomes 1 and 4, or a locus specific identifier for c-myc. Three lots of hMSCs and three human cancer cell lines (HeLa S3, HOS and OUMS-27) were analyzed. The results of this study suggest that both observation of cell morphology and FISH analysis of c-myc aberrant cells in interphase cells are useful for evaluating safety of hMSCs expanded in vitro.
- 1 January 2010
- No. 128,p. 50-7
[Cytogenetic study on safety evaluation of human mesenchymal stem cells cultured in vitro].
Human mesenchymal stem cells (hMSCs) are one of the promising sources for regenerative medicine. In general, hMSCs are supposed to grow indefinitely and differentiate to various kinds of cells. The indefinite growth is concerned due to its misleading to carcinogenesis in the practical use of hMSCs in regenerative medicine. In the present study, we investigated unexpected changes, especially in genetic aspect, in hMSCs during culture utilizing fluorescence in situ hybridization (FISH) with chromosome specific DNA probes for chromosomes 1 and 4, or a locus specific identifier for c-myc. Three lots of hMSCs and three human cancer cell lines (HeLa S3, HOS and OUMS-27) were analyzed. The results of this study suggest that both observation of cell morphology and FISH analysis of c-myc aberrant cells in interphase cells are useful for evaluating safety of hMSCs expanded in vitro.
- 1 January 2009
- Published by SAGE Publications in Bio-Medical Materials and Engineering
- Vol. 19 (1) , 19-27
Development of an in vitro screening method for safety evaluation of nanomaterials
To evaluate the role of particle size in cytotoxicity tests of nanomaterials (NMs), we exposed Chinese hamster cells to polystyrene (PS) spheres with defined diameters ranging from 0.1 to 9.2 μm. We found that the 4.45-μm PS particles were most cytotoxic while sizes 0.1 and 0.2 μm showed no cytotoxicity up to 1000 μg/ml. In the chromosome aberration test, the 4.45-μm PS particles induced polyploidy in a mass concentration-dependent manner in 24- and 48-h treatments. The 5.26-μm PS particles induced polyploidy only at 1000 μg/ml for 48 h. Next, we performed the cytotoxicity test with as-grown single walled carbon nanohorns (NHas). These were suspended in DMSO and then transferred into the culture medium followed by sonication. Six suspensions differently sonicated showed the same apparent toxicity, although the total particle size distributions differed. However, the sizes of NHas particles predicted to be most toxic from the experiments with PS particles, i.e. 1.01–4.47 μm constituted 40–60% of all particles in all six suspensions. The results suggest that the cytotoxicity of NMs in suspension depends on specific sizes of aggregates and therefore suspensions should be checked with regard to particle size distributions in assays of toxic effects. The uptake of particles into cells was confirmed by confocal microscopy.
- 1 January 2009
- Published by SAGE Publications in Bio-Medical Materials and Engineering
- Vol. 19 (1) , 19-27
Development of an in vitro screening method for safety evaluation of nanomaterials
To evaluate the role of particle size in cytotoxicity tests of nanomaterials (NMs), we exposed Chinese hamster cells to polystyrene (PS) spheres with defined diameters ranging from 0.1 to 9.2 μm. We found that the 4.45-μm PS particles were most cytotoxic while sizes 0.1 and 0.2 μm showed no cytotoxicity up to 1000 μg/ml. In the chromosome aberration test, the 4.45-μm PS particles induced polyploidy in a mass concentration-dependent manner in 24- and 48-h treatments. The 5.26-μm PS particles induced polyploidy only at 1000 μg/ml for 48 h. Next, we performed the cytotoxicity test with as-grown single walled carbon nanohorns (NHas). These were suspended in DMSO and then transferred into the culture medium followed by sonication. Six suspensions differently sonicated showed the same apparent toxicity, although the total particle size distributions differed. However, the sizes of NHas particles predicted to be most toxic from the experiments with PS particles, i.e. 1.01–4.47 μm constituted 40–60% of all particles in all six suspensions. The results suggest that the cytotoxicity of NMs in suspension depends on specific sizes of aggregates and therefore suspensions should be checked with regard to particle size distributions in assays of toxic effects. The uptake of particles into cells was confirmed by confocal microscopy.
- 1 March 2008
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 46 (3) , 1125-1130
A pilot study of evaluation of the antioxidative activity of resveratrol and its analogue in a 6-month feeding test in young adult mice
- 1 March 2008
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 46 (3) , 1125-1130
A pilot study of evaluation of the antioxidative activity of resveratrol and its analogue in a 6-month feeding test in young adult mice
- 16 October 2007
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 86A (1) , 13-22
Organic‐solvent extraction of model biomaterials for use in the in vitro chromosome aberration test
We prepared polyurethane (PU) containing 0.4% or 4% 4,4′‐methylenedianiline (MDA) as model materials to investigate the effectiveness of sample preparation by organic‐solvent extraction for the in vitro chromosome aberration (CA) test. MDA itself (0.4 mg/mL) was positive only in the presence of an exogenous metabolizing system (S9 mix). The culture medium extract of PU containing 4% MDA (PU/4% MDA) was negative with and without S9 mix. Methanol and acetone extracts, on the other hand, induced structural CAs without S9 mix, which we did not expect because MDA requires S9 mix for activity. On chemical analysis, however, we found that the ratio of MDA extracted by the organic solvents to that extracted by the culture medium of PU/4% MDA was about 15:1. Interestingly, oligomers consisting of poly(tetramethyleneglycol) derivatives (OTMG) were also extracted by the organic solvents. The data suggest that the induction of structural CAs in the absence of S9 mix may have been partly due to synergism of MDA and OTMG. CA tests of MDA and PTMG‐1000 in combination confirmed that to be the case. Thus, organic‐solvent extraction may be more effective than medium extraction in evaluating the biological safety of biomaterials. Detailed chemical analysis of extracts was performed. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
- 16 October 2007
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 86A (1) , 13-22
Organic‐solvent extraction of model biomaterials for use in the in vitro chromosome aberration test
We prepared polyurethane (PU) containing 0.4% or 4% 4,4′‐methylenedianiline (MDA) as model materials to investigate the effectiveness of sample preparation by organic‐solvent extraction for the in vitro chromosome aberration (CA) test. MDA itself (0.4 mg/mL) was positive only in the presence of an exogenous metabolizing system (S9 mix). The culture medium extract of PU containing 4% MDA (PU/4% MDA) was negative with and without S9 mix. Methanol and acetone extracts, on the other hand, induced structural CAs without S9 mix, which we did not expect because MDA requires S9 mix for activity. On chemical analysis, however, we found that the ratio of MDA extracted by the organic solvents to that extracted by the culture medium of PU/4% MDA was about 15:1. Interestingly, oligomers consisting of poly(tetramethyleneglycol) derivatives (OTMG) were also extracted by the organic solvents. The data suggest that the induction of structural CAs in the absence of S9 mix may have been partly due to synergism of MDA and OTMG. CA tests of MDA and PTMG‐1000 in combination confirmed that to be the case. Thus, organic‐solvent extraction may be more effective than medium extraction in evaluating the biological safety of biomaterials. Detailed chemical analysis of extracts was performed. © 2007 Wiley Periodicals, Inc. J Biomed Mater Res, 2008
- 1 August 2007
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 4 (2) , 69-76
A novel candidate compound with urethane structure for anticancer drug development.
Abstract: Diethyl-4,4-methylenebis(N-phenylcarbamate) (MDU) is a urethane compound that we originally synthesized, along with three other compounds, to investigate how polyurethane is hydrolysed. We tested the four compounds for cytotoxicity in two Chinese hamster cell lines (CHL and V79) and a human cancer cell line (HeLa S3). MDU showed the strongest cytotoxicity in all the cell lines with an IC50 of around 0.1 μg/ml. We further investigated MDU for its ability to induce chromosome aberrations (CAs) and micronuclei (MN) in CHL cells. MDU induced around 100% polyploid cells at 0.5 μg/ml after 24- and 48-h treatment in the CA test and a significantly increased frequency of micronuclei, polynuclear cells, and mitotic cells in the MN test, suggesting that it may induce numerical CAs. MDUs ability to cause mitotic arrest in CHL cells was greater than that of taxol and colchicine. Based on a COMPARE analysis using JFCR39, a panel of cancer cell lines, we predicted MDU to be a tubulin inhibitor. We confirmed this possibility in nerve growth factor- stimulated PC12 cells as well as in HT1080 cells, in which MDU exhibited the activity to inhibit tubulin polymerization. MDU is simpler in structure than existing anticancer drugs taxol and vincristine and can be synthesized relatively easily. Here we offer MDU as a potential new type of anticancer drug, stable even at room temperature, and inexpensive.
- 1 August 2007
- Published by Bentham Science Publishers Ltd. in Current Drug Discovery Technologies
- Vol. 4 (2) , 69-76
A novel candidate compound with urethane structure for anticancer drug development.
Abstract: Diethyl-4,4-methylenebis(N-phenylcarbamate) (MDU) is a urethane compound that we originally synthesized, along with three other compounds, to investigate how polyurethane is hydrolysed. We tested the four compounds for cytotoxicity in two Chinese hamster cell lines (CHL and V79) and a human cancer cell line (HeLa S3). MDU showed the strongest cytotoxicity in all the cell lines with an IC50 of around 0.1 μg/ml. We further investigated MDU for its ability to induce chromosome aberrations (CAs) and micronuclei (MN) in CHL cells. MDU induced around 100% polyploid cells at 0.5 μg/ml after 24- and 48-h treatment in the CA test and a significantly increased frequency of micronuclei, polynuclear cells, and mitotic cells in the MN test, suggesting that it may induce numerical CAs. MDUs ability to cause mitotic arrest in CHL cells was greater than that of taxol and colchicine. Based on a COMPARE analysis using JFCR39, a panel of cancer cell lines, we predicted MDU to be a tubulin inhibitor. We confirmed this possibility in nerve growth factor- stimulated PC12 cells as well as in HT1080 cells, in which MDU exhibited the activity to inhibit tubulin polymerization. MDU is simpler in structure than existing anticancer drugs taxol and vincristine and can be synthesized relatively easily. Here we offer MDU as a potential new type of anticancer drug, stable even at room temperature, and inexpensive.
- 8 August 2005
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 75A (2) , 439-444
In vitro induction of polyploidy and chromatid exchanges by culture medium extracts of natural rubbers compounded with 2‐mercaptobenzothiazole as a positive control candidate for genotoxicity tests
We tested extracts of custom‐made natural rubber samples for cytotoxicity using V79 cells and for chromosome aberration (CA) induction using CHL cells in compliance with the Japanese guidelines for basic biological tests of medical materials and devices. The samples were formulated with a high level of 2‐mercaptobenzothiazole (MBT) (A); a low level of MBT (B); or zinc dibutyldithiocarbamate (ZDBC) (C). In the CA test, MBT induced mainly polyploidy, including endoreduplication, and ZDBC induced structural CAs. In the cytotoxicity test, culture medium extracts of A, B, and C suppressed colony formation to 50% of the control value at 53.1%, 94.3%, and >100%, respectively. Culture medium extracts of sample A induced polyploidy and structural CAs in the absence of an exogenous metabolic activation system (S9 mix), but at lower concentrations in its presence, indicating the existence of other leachable promutagens. The extracts of sample B induced structural CAs at the highest concentration and only with S9 mix. Sample C was negative. The facts suggest that sample A may be a candidate for a positive control for genotoxicity tests. The high frequency of polyploidy induced by sample A was not predicted by MBT, suggesting the usefulness of the test for safety evaluation of medical devices. Numerical CAs induced by MBT and sample A are discussed. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005
- 8 August 2005
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 75A (2) , 439-444
In vitro induction of polyploidy and chromatid exchanges by culture medium extracts of natural rubbers compounded with 2‐mercaptobenzothiazole as a positive control candidate for genotoxicity tests
We tested extracts of custom‐made natural rubber samples for cytotoxicity using V79 cells and for chromosome aberration (CA) induction using CHL cells in compliance with the Japanese guidelines for basic biological tests of medical materials and devices. The samples were formulated with a high level of 2‐mercaptobenzothiazole (MBT) (A); a low level of MBT (B); or zinc dibutyldithiocarbamate (ZDBC) (C). In the CA test, MBT induced mainly polyploidy, including endoreduplication, and ZDBC induced structural CAs. In the cytotoxicity test, culture medium extracts of A, B, and C suppressed colony formation to 50% of the control value at 53.1%, 94.3%, and >100%, respectively. Culture medium extracts of sample A induced polyploidy and structural CAs in the absence of an exogenous metabolic activation system (S9 mix), but at lower concentrations in its presence, indicating the existence of other leachable promutagens. The extracts of sample B induced structural CAs at the highest concentration and only with S9 mix. Sample C was negative. The facts suggest that sample A may be a candidate for a positive control for genotoxicity tests. The high frequency of polyploidy induced by sample A was not predicted by MBT, suggesting the usefulness of the test for safety evaluation of medical devices. Numerical CAs induced by MBT and sample A are discussed. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005
- 1 March 2004
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 547 (1-2) , 101-107
Correlation of sister chromatid exchange formation through homologous recombination with ribonucleotide reductase inhibition
- 1 March 2004
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 547 (1-2) , 101-107
Correlation of sister chromatid exchange formation through homologous recombination with ribonucleotide reductase inhibition